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Edited by Veli-Pekka LehtoAbstract Fibrinogen conjugated gold nanoparticles (ﬁbrino-
gen–Au) and thrombin conjugated silver nanoparticles (throm-
bin–Ag) were synthesized by heating (90 C) the proteins
(50 lg protein/ml) with 1 mM AgNO3 or AuCl3. The resultant
particles were harvested and examined by ﬂow cytometry, scan-
ning electron microscopy (SEM), transmission emission micro-
scopy (TEM), optical microscopy and dynamic light scattering.
SEM and TEM images revealed that the ﬁbrinogen–Au and
thrombin–Ag particles interacted. The emergent bio-nanoconju-
gate population could be controlled by addition of thrombin–
Ag. The method may be exploited in parametrizing coagulation
factors and other clinically important protein–protein interac-
tions.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Self-assembly1. Introduction
Recently, nanomaterials are extensively ﬁnding their use in
biological ﬁelds as biosensors, drug delivery systems, bio-con-
jugates, ﬂuorescent probes, etc. [1]. The advantage of the nano-
particles as the conjugate to the biomolecules lies in the special
physical properties of the nanoform emerging due to conjuga-
tion. The optical as well as the structural properties of the
nanoforms are highly sensitive and easily detectable. Hence,
nanoparticles have the capabilities to enhance the detection
of biochemical processes when the participating molecules
are conjugated with the nanoforms. Thus protein–protein
interaction can eﬀectively be visualized by observing the mu-
tual interaction between nanoparticles.
In the present work, we have introduced a ﬂow cytometry
based technique to observe as well as to quantify the key reac-
tion of blood clotting, i.e. the reaction between nanoconjugat-
ed ﬁbrinogen and thrombin. As the reaction leads to formation*Corresponding author. Fax: +91 33 24614849.
E-mail address: adgcal@gmail.com (A.K. Dasgupta).
URL: http://biochem.caluniv.in.
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.10.049of near micron level structures the population of nanoclusters
is conveniently detected by ﬂow cytometry from the scattering
behavior of interacting molecules and their proteolysis prod-
uct.
The ﬁbrinogen–thrombin interaction is a part of the physio-
logical process of blood clotting. The reaction cascade leading
to the ﬁnal step comprises the chemical reaction between the
serine protease thrombin and the precursor protein ﬁbrinogen
(with subunit Aa2Bb2c2) to form ﬁbrin clots. The reaction in-
volves the proteolytic cleavage of ﬁbrinogen by thrombin. The
cleavage takes place between Arg16 and Gly17 of subunit
Aaand between Arg14 and Gly15 of subunit Bb to form ﬁbri-
nopeptide A and B [2].
This release of ﬁbrinopeptides activates the formation of
protoﬁbrils. Mechanistically, it is known that the release of
the ﬁbrinopeptide A leads to the exposure of the GPR knob
(Gly-Pro-Arg-) that can ﬁt into ‘‘holes’’ on the distally located
c-chain carboxyl domains of ﬁbrinogen. Extension of the pro-
cess leads to the formation of the intermediate protoﬁbrils.
Upon the interaction with the clotting factor XIII these pro-
toﬁbrils are transformed in to hard clots. Recently, the detail
mechanism is proposed by Yang et al. [3] based on the crystal
structure of the proteins. Diﬀerent knob–hole interactions,
inter-chain interaction, parallel alignments of the protoﬁbrils
were proposed. Thus the ﬁbrin formation plays a key role in
maintaining the physiological homeostasis. Any alteration of
this ﬁbrin formation leads to various physiological disorders.
Primary manifestation of the disorder results in dysﬁbrinoge-
nemia associated with arterial or venous thrombosis [4]. The
basic reason behind this thrombosis is the defective binding be-
tween thrombin and ﬁbrin generated from defective ﬁbrinogen
[5]. Hence, a vivid observation of this process may provide us
vital information regarding the related pathogenesis. Hence, if
conjugating the interacting proteins with nanoparticles
enhances the observation of the reaction, the detection of the
process becomes easier.
There have been successful eﬀorts made previously to ob-
serve biochemical reactions by the conjugation with nanosur-
face. The work of Dong et al. [6] has shown for the ﬁrst time
a quantitative photoelectrochemical detection of a biological
aﬃnity interaction between biotin and avidin using protein
nanoparticle conjugation in the electrode. It goes to show that
the biomolecule conjugation to the nanosurface may be eﬀec-
tively utilized to describe a biochemical reaction. However,
the aim of conjugating a protein to the nanosurface is largely
to enhance the detection horizon of the protein. The interac-
tion between the nanoforms conjugated with interactingblished by Elsevier B.V. All rights reserved.
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the nanoparticle response. The thermodynamic aspects of the
biomimetic studies have been investigated recently [7]. Gold
nanoparticle is now a very popular target for protein metalli-
zation. Gold nanoparticle has been successfully conjugated
with diﬀerent globular proteins [8], like Bovine serum albumin
[9], cytochrome c [10], etc. Gold nanoparticles have also been
stabilized by lysozyme monolayer [11], apo-ferritin [12], ribo-
nuclease-S [13] and fungal protease [14]. Gold nanoparticles
have been successfully used to determine the glycation state
of protein [15]. Additionally, both the silver and gold nanopar-
ticle have been employed to develop bioassays against variety
of target species [16]. The hemoprotein bioconjugates with
both silver and gold nanoparticles and gold nanorods have
been achieved keeping the heme attachment intact [17].
There are reports of the metallization of the ﬁbrinogen. The
uptake study of calcium is important. The calcium uptake was
correlated with the ﬁbrinopeptides release [18]. It was observed
that the release of ﬁbrinopeptide B follows parallel to binding
of calcium. Interestingly, the release of ﬁbrinopeptide A is
much faster. There are further studies about the calcium bind-
ing with ﬁbrinogen to unveil the mechanism of the calcium
binding with ﬁbrinogen Ca-binding site during ﬁbril formation
[19]. The interaction of ﬁbrin with the drug carbo-platin
deserves mention [20]. The interaction was studied by aggrego-
metry and then calculating the clotting time. In that case, the
metallic nanoparticle was found to be embedded in the ﬁbrin
mesh.
Recently, Jiang et al. [21] have reported the nanoparticle
conjugated immuno assay using gold nanoparticle conjugated
goat anti-human ﬁbrinogen with ﬁbrinogen. They designed the
assay to determine trace amount of ﬁbrinogen. In this work,
we have conjugated ﬁbrinogen with gold nanoparticle and
thrombin with silver nanoparticle and our detection system
is based on ﬂow cytometry. We have tried to see how the met-
allized ﬁbrinogen and thrombin interact with each other lead-
ing to the formation of any metallic derivative of ﬁbrin. With
addition, we are trying to study the kinetics of protein conju-
gation to the metal surface during the formation of nanoparti-
cles.
Another important aspect of this work is the mode of detec-
tion of the interaction. The chemistry between the synthetically
formed nanoforms (like gold, silver nanoparticles, etc.) and the
evolutionary formed nanoforms (like protein, nucleic acid,
etc.) has been studied on the basis of their physico-chemical
properties (like size, absorption, ﬂuorescence property, electro
kinetic properties, etc.). Here we put an emphasis on the
importance of geometrical properties. How the interaction be-
tween diﬀerent protein-conjugated nanoparticles lead to the
formation of an assembly with a new shape and geometry
has been given prime importance. In the empirical sense, the
dimension factors of the reactant nanoforms and emerging
assemblies during reaction will be considered with importance.
But, the study of this geometrical transition due to interaction
in a dynamic system is not commonplace. We have introduced
a technique based on ﬂow-cytometry as an eﬀective tool to
serve the purpose. Flow-cytometry technology has now
emerged as an indispensable tool in diagnostics; say of hema-
tological malignancies utilizing new antibodies [22], improved
gating strategies, and routine use of multi-parameter tech-
niques. This is primarily used to view various cells on the basis
of their topographic as well as ﬂurophoric features, which areunique to diﬀerent cell types. The former feature actually iden-
tiﬁes the geometrical parameters of a substance. This method
of identiﬁcation is here employed to analyze the geometrical
transitions during the interaction between the nanoforms.
We are concentrating on mainly two parameters: forward scat-
tering (FSC) and side scattering (SSC). The ﬁrst one represents
the size and the later represents the granularity of a population
under ﬂow. So, any kind of assembly reaction like ﬁbrin for-
mation will result in the generation of polymeric population
with higher granularity. So, if metal nanoparticle conjugated
proteins (here ﬁbrinogen and thrombin) interact to form high-
er assembly (metal conjugated ﬁbrin type assembly), it will be
reﬂected in the corresponding scattering domain of the ﬂow
cytometry. We will try to observe any possible interaction lead-
ing to such assembly formation.
Choice of the diﬀerent nanoparticles (gold for ﬁbrinogen and
silver for thrombin) instead of one is due to their inherent dif-
ference of population distribution pattern in diﬀerent data
acquisition modes of ﬂow cytometry. Importantly, our method
does not require any antibody or ﬂuorescent tags for the iden-
tiﬁcation. The response of the conjugated nanoparticles to the
ﬂow system itself is the detection system.2. Materials and methods
2.1. Reagents
Auric chloride was purchased from Arora Matheys. Silver nitrate,
tri-sodium citrate di-hydrate and sodium borohydride were purchased
from Merck and ﬁbrinogen and thrombin were purchased from Dade
Behring, USA. The proteins (Bovine serum albumin, cytochrome c and
hemoglobin) were procured from Sigma–Aldrich, USA.2.2. Fibrinogen coated gold nanoparticles (ﬁbrinogen–Au)
AuCl3 (4 mM) solution was mixed with ﬁbrinogen (concentration
50 lg/ml). Sodium citrate (150 lM) was added to the mixture and
was heated with stirring at 90 C for 30 min. The color of the solution
slowly turned to violet. After the complete reduction the oxidation
state of Au becomes 0 (Au) from +3 (in AuCl3). The solution was then
cooled and kept at room temperature (25 C) for 2 h. The wavelength
maximum was found at 536 nm (see Fig. 2A). The optimum ratio for
molar concentration of ﬁbrinogen:Au has been found to be 15:1. One
single protein can conjugate with a number of metal nanoparticles by
sulfur containing (like thiol group; –SH) or nitrogen containing (like
amine group; –NH2) amino acid residue. Due to this diversity of inter-
action between protein and nanoparticle there appears a multimeric
binding of protein with nanosurface and diversity of size emerges.
Hence a large size protein (here ﬁbrinogen), when seeded on nanosur-
face, leads to the formation of a protein-conjugated nanoparticle pop-
ulation with slight size diversity.2.3. Thrombin coated silver nanoparticles (thrombin–Ag)
AgNO3 solution (1 mM) was mixed with thrombin (concentration
50 lg/ml). Sodium citrate (150 lM) was added to the mixture and
was heated with vigorous stirring at 90 C for 30 min. The color grad-
ually turns to yellowish brown. A dilute NaBH4 solution (100 lM) was
then added drop wise to the solution of the citrate stabled silver–
thrombin conjugate. The solution turned to bright greenish yellow.
The oxidation state is reduced from +1 (AgNO3) to 0 (Ag) due to
reduction. The wavelength maximum was observed to be 400 nm
(see Fig. 3A). The optimum ratio for molar concentration of throm-
bin–Ag has been found to be 30:1.
2.4. Storage of nanoforms
After the heat induced protein metallization step (for 30 min) the
reaction mixture is cooled to room temperature (25 C). Then their
hydrodynamic size (Dh) distribution is measured by Dynamic Light
Scattering by scanning the samples several times. Appearance of a sin-
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(PDI) value suggests the generation of stable and monodisperse nano-
particle population. Then the stabilized nanoparticle solution is kept in
glassware at room temperature (25 C). They are perfectly stable for
around one month.
2.5. Transmission electron microscopy (TEM)
We have used the instrument FEI (Czech Republic), type FP 5018/40
TECHNAI G2 SPIRIT BioTWIN. To obtain proper resolution of the
small sized nanoparticle we have used 100 kV voltage and 300000 mag-
niﬁcation.2.6. Spectrophotometry
For the characterization and interaction experiments of the synthe-
sized nanoparticles, we have used diode-array spectrophotometer Ana-
lytic Jena (spekol-1200).
2.7. Scanning electron microscopy (SEM)
To observe the morphological aspect of the protein-nanoform con-
jugate interaction we have used SEM of Hitachi S-2300. The voltage
used here is 25 kV with various magniﬁcations.2.8. Optical microscopy
Slides were prepared for microscopic examination using Olympus
BX51 microscope, of nanoform protein complex. Three or four drops
of the complex were placed on a slide and were subjected to examina-
tion by bright ﬁeld microscopy. While the cluster morphology can be
better seen at higher magniﬁcation (1000·), a more robust statistical
distribution of the cluster was obtained at magniﬁcation (400·) using
40· objective. The image thus obtained was analyzed using Olympus
MicroImage software.Fig. 1. (A) The TEM picture for ﬁbrinogen–Au at 100 kV voltage and
300000 magniﬁcation. (B) The TEM picture for thrombin–Ag at
identical condition.2.9. Flow cytometry
For this technique we have used FACSCalibur (BD Biosciences).
The excitation source is 15 mW 488 nm, air-cooled argon-ion laser (life
expectancy >5000 h). Optional second red diode laser (He–Ne source)
of wave length 632 nm The primary data acquisition mode involve the
plotting of forward and side scattering signals (FSC–SSC dot plot) for
having a visual description of size and granularity, respectively. In
addition to the FSC–SSC plot this instrument has diﬀerent channels
and detectors for diﬀerent wavelength emissions after the sample is
encountered by lasers of ﬁxed wave lengths. If the sample population
is ﬂuorophoric or ﬂuorescence tagged, the emission of the light is ob-
served in the corresponding wavelength ranges (e.g. ﬂ1, ﬂ2, ﬂ3 and ﬂ4).
Any kind of energy state perturbation due to any interaction will lead
to an altered population distribution emerging in the corresponding
acquisition mode (e.g. FSC–SSC plot). The channel voltage was taken
as for FSC – E00 and for SSC it is 350. The threshold value was taken
as 52.
The dot plot obtained from the FACSCalibur is then fed to WIN-
MDI software which transfers the dot plots containing 10,000 data
points to numeral (tabbed text) chart. It is then analyzed by a program,
which counts the two population (native and emerging) domains
ﬁnally yielding the percentage contribution of the individual popula-
tions. The percentage contribution of the nascent population has been
utilized as the percentage-binding fraction. This binding fraction has
been used to calculate the interaction parameters like dissociation con-
stant, Hill coeﬃcient, etc.
2.9.1. Dynamic light scattering and laser Doppler velocimetry. The
Nano-ZS (Malvern) instrument we have used for our experiment is
equipped with a 4 mW He–Ne laser (k = 632 nm). The sample is
poured in a 3 ml glass cuvette (path length 1 cm) with all transparent
walls. Prior to the DLS study, protein samples were ﬁltered through
a 2 lm membrane ﬁlter (Acrodisc). The operating procedure was pro-
gramed (using the DTS software supplied with the instrument) such
that there are average 20 runs, each being averaged for 10 s, and a par-
ticular Rh is computed in each case and ultimately the result is pre-
sented as the distribution of Rh. A particular hydrodynamic
diameter (Dh) is evaluated several times and the result is presented in
terms of a distribution of the hydration diameter. The instrument pro-
vided the size distribution in: (a) intensity mode, (b) volume mode and
(c) number mode. For monitoring the population of nanoconjugates,
number mode intensity distribution was used.3. Results
3.1. Observation of the nanoforms under TEM
The protein coated metallic nanoparticles seen under TEM
is described in Fig. 1. The distribution of the nanoparticles var-
ies from ﬁbrinogen–Au to thrombin–Ag. In Fig. 1A, the dis-
perse population of the ﬁbrinogen–Au nanoparticle shows an
average diameter of 12.8 ± 3.1 nm. The thrombin–Ag popula-
tion (see Fig. 1B) is found as cluster. The average size of the
population is 9.1 ± 4.1 nm. Hence, the size of the nanoparticle
conjugated with higher size protein (i.e. ﬁbrinogen) is higher
than the nanoparticle conjugated with smaller sized protein
(thrombin). It should be noted that the thrombin–Ag has the
tendency to stay as clusters while the ﬁbrinogen–Au remains
well dispersed.
3.2. Spectral study of ﬁbrinogen–Au by thrombin–Ag
The conjugation of ﬁbrinogen to gold nanoparticle shows
two important stages of reaction (see Fig. 2A). Stage 1 is char-
acterized by the gradual assimilation of the peptide peak in to
the nanosurface within 2 min. The spectra remain unchanged
till 10 min of the reaction. In stage 2 (after the conjugation)
the characteristic peak of the gold nanoparticle appears after
10 min. The peak at 536 nm now increases gradually and a sig-
moid like growth curve appears (see Fig. 2B). When we studied
the kinetics in detail, a second-order kinetics was observed.
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dx
dt ¼ kðx x0Þ2 þ C the ﬁtted curve being shown Fig. 2C.
To compare this ﬁnding with the two-stage kinetics men-
tioned earlier, it has been observed in Fig. 2A (right panel) that
the nanoparticle peak becomes distinctively clear at around
15 min and at the vicinity of the absorbance 0.3. This clearly
indicates that the initial evolution of the nanoparticle peak
(after protein conjugation to the nanosurface) is the fastest
step of the whole kinetics. Both the protein metallization and
the concentrating of the ﬁbrinogen–Au are the slower steps.
Importantly, the mechanism of the thrombin to silver nano-
particle conjugation is much diﬀerent. The metallization ofFig. 2. (A) The formation of ﬁbrinogen–Au is shown by two stages of spectra
and the right panel is stage 2 that shows the evolution of ﬁbrinogen–Au. (B) S
the nanoparticle peak 536 nm with time. (C) Fits with a second-order reactithrombin in presence of the strong reducing agent NaBH4
shows a very fast kinetics to attain saturation. In Fig. 3A,
the whole spectra of thrombin–Ag formation are given. The
spectra are the 10-min scan with 5-s interval (i.e. the overlap
of 120 scans). The characteristic silver nanoparticle peak at
400 nm, increases with time. This is accompanied with the
appearance of isosbestic points (at 357 nm and 522 nm). This
simultaneous appearance of these isosbestic points indicates
the presence of the reaction intermediates during conjugation.
This isosbestic point is also indicative of the change of energy
state. The kinetics of the formation is given in the Fig. 3B. This
shows the increment of the absorbance corresponding to thel overlap. The left panel is stage 1 that denotes the protein metallization
hows the time kinetics of the formation with the plot of absorbance of
on.
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shows a fast saturation within almost 30 s. It soon saturates
to form the thrombin–Ag.Fig. 3. (A) The formation of thrombin–Ag is shown. Spectra (120) are overl
isosbestic points have emerged at 357 nm and 522 nm, respectively. The ti
absorbance at 400 nm, which is the peak of the conjugated silver nanoparticle
for ﬁrst 30 s; then it saturates.The reaction rate is of the order of zero at the earlier stage of
30 s (see Fig. 3C) as indicated with the initial straight line for
the low concentration range in the ﬁtting model.apped to describe the formation of thrombin–Ag (at 5 s interval). Two
me kinetics (B) of the formation was observed as the kinetics of the
s. (C) The ﬁtting model for the kinetic, which shows that order of zero
Fig. 4. The scanning electron microscopy was performed to compare the naturally formed ﬁbrin topology with the nanoparticle modiﬁed ﬁbrin type
assembly. A (a and b) Naturally formed ﬁbrin network with high and low resolution, respectively. B (a–c) The altered ﬁbrin type assembly by the
association ob ﬁbrinogen–Au and thrombin–Ag. The disjoined ﬁber was magniﬁed to further characterize the topology.
Fig. 5. The FSC–SSC plot of silver nanoparticles with and without
conjugation of various proteins (cytochrome c, BSA, hemoglobin and
thrombin).
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conjugated nanoforms, we conclude that the ﬁbrinogen–Au
formation is a slow, two-stage process divided in protein met-
allization and nanoparticle formation; where as the formation
of thrombin–Ag is fast and characterized by concomitant gen-
eration of nanoparticle with protein metallization.
3.3. SEM indicates altered ﬁbrin formation after metallization
SEM pictures show (Fig. 4A) a ﬁbrin network formed from
the interaction between pure ﬁbrinogen and thrombin. But
their concentration is kept very low (ﬁbrinogen concentration
50 lg/ml) to compare the eﬀect of metallization on protein.
When ﬁbrinogen–Au is mixed with thrombin–Ag, the resultant
mixture is observed under SEM and is shown in Fig. 4B. In-
stead of a ﬁbrin network an extended structure of nano-protein
conjugate spreads over the ﬁeld. This is clear from the genera-
tion of a disjoined ﬁbre type assembly with 500–1000 nm
length. Higher magniﬁcations (Fig. 4B, b and c) show the
inclusion of the nanoparticles within the assembly.
3.4. Flow cytometric appraisal of the protein–protein interaction
Diﬀerent nanoparticle assemblies are characterized as their
population distribution in the diﬀerent acquisition modes of
the ﬂow cytometry. Gold and silver nanoparticles give speciﬁc
distribution of the population count in the FSC–SSC dot plot.
The main observation that is worth mentioning is appear-
ance of bifurcated ﬂow cytometric plots in some cases. Such
plots may appear in individual proteins (Fig. 5) and also as a
result of some protein–protein interaction (Fig. 6A). The ﬂow
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protein–protein interaction will be devoid of any ambiguity
provided the corresponding interacting proteins exhibit mono-
modal ﬂow cytometric distribution. On the other hand the ﬂow
cytometric pattern can be used to quantify the interaction
(Fig. 6B) from the relative branch intensities in the bifurcated
plot.
Individual metallic nanoparticle shows distinguished pattern
in population distribution in the FSC–SSC plot. It is evident
from Fig. 5 silver nanoparticles have shown variations in pat-
tern when conjugated to diﬀerent nanoparticles. Protein-conju-
gated gold nanoparticles do not show such protein speciﬁc
diversity (data not shown) in the FSC–SSC plane. Thus
(AgNP) conjugation with diﬀerent proteins (cytochrome c
(Cyt-c–Ag), BSA (BSA–Ag), hemoglobin (hemoglobin–Ag),
thrombin (thrombin–Ag), etc.) showed distinguished popula-
tion distribution in the FSC–SSC plot. Due to this diverse
interaction of Silver nanoparticles with diﬀerent proteins, it
has been chosen as the titrating component of the reaction.
The distribution of ﬁbrinogen–Au displays high FSC signal
and low SSC signal values and that of thrombin–Ag is distrib-Fig. 6. The ﬂow cytometry detection of the ﬁbrin formation. (A) The FSC v
Boxes I–X show the dot plot of the ﬁbrinogen–Au in presence of thromb
respectively. The ratios of the two populations (in %) have been plotted aga
(B).uted mainly in high SSC signal. This diﬀerence in distribution
will be helpful to study the interaction between the two. These
primary observations have led to the choice of gold and silver
nanoparticles as the conjugating partners for ﬁbrinogen (to be
titrated) and thrombin (titrating agent), respectively.
In the FSC–SSC plot of the instrumentation ﬁbrinogen–Au
and thrombin–Ag gives the speciﬁc population distribution
upon interaction. The ﬁbrinogen–Au population is more to-
wards FSC axis where as the thrombin–Ag is more towards
SSC axis. We titrated the ﬁbrinogen–Au with thrombin–Ag
(see Fig. 6A). The distribution of 30 nM of ﬁbrinogen–Au
was aﬀected signiﬁcantly when 50 ll of the thrombin–Ag
(3 nM) is introduced to the system. The change describes the
gradual increase of the population density in the SSC axis rep-
resenting gradual formation of the assembly of nano-bioconju-
gates as a result of the interaction between ﬁbrinogen–Au and
thrombin–Ag with decrease in the population near the FSC
axis, which represents unreacted ﬁbrinogen–Au. With increas-
ing titre volume of thrombin–Ag up to 500 ll (30 nM) the
emerging population near the SSC axis totally dominates the
dot plot and the ﬁbrinogen–Au population almost vanishes.s. SSC plot of the ﬁbrinogen–Au (30 nM) titrated with thrombin–Ag.
in–Ag of the concentration 0, 3, 6, 9, 12,15, 18, 21, 24 and 30 nM,
inst corresponding thrombin concentration to get the binding curve in
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interacted with the thrombin–Ag to form assembly having al-
tered cluster distribution of gold and silver nanoparticles.Fig. 7. The self-assembly of the conjugated nanoforms has been observed und
of the protein conjugation to the metal surface. Diﬀerent patterns are forming
self-assembly in diﬀerent panels. The three upper panels show smaller cluste
pattern forming cluster, (II) incomplete cluster, (III) compact micro cluste
thrombin–Ag is given in (B) with small (I) and medium (II) cluster associatio
been well observed by the structural dynamics of the interacting ﬁbrinogen–
panel describes the aggregation and the assembly formed as a result of the a3.5. Quantiﬁcation of the interaction parameters
From this interplay between these two population observed in
the FSC vs. SSC dot plot, we have quantiﬁed the new emerginger bright ﬁeld microscope. These micron size clusters show the diversity
as a result of the various mode of conjugation. (A) Various patterns of
rs and the two lower panels show large clusters. The panels show (I)
r and (IV) and (V) show large self-assembly. The microstructure of
n. The observation of nanoconjugated protein aggregate formation has
Au and thrombin–Ag (1:1 volume) is shown in two stages in (C). The
ggregated protein nanoparticle conjugates (C (I)–(IV)).
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the individual dots in each split population shown in the popu-
lation counter data set. Each dataset contained 10,000 data
points on the corresponding plot. By assigning the distribution
of these 10,000 points into two clearly divided population do-
mains, the points in each domain were counted. The fraction
of the counts corresponding to protein bound and free nano-
formwas calculated. This fraction, then converted to percentage
has been taken as the parameter of interacting nanoconjugate
population. Now, a binding curve for this interaction has been
constructed by using the fraction of the population (converted
to %) as the arbitrary unit of binding (see Fig. 6B).
3.6. Characterization of the self-assembled nanoclusters under
bright ﬁeld microscopy
Synthesized nanoforms have been observed under bright
ﬁeld microscopy. 10 ll of the nanoparticles (ﬁbrinogen–Au
and thrombin–Ag) have been taken on a slide. Another sample
containing 1:1 volume mixture of ﬁbrinogen–Au and throm-
bin–Ag was ﬁrst incubated for an hour and then 10 ll of the
mixture was taken for the observation.
The images show an interesting breed of self-assembly for
ﬁbrinogen–Au (see Fig. 7A). This assembly contains both mi-
cro and macro structures. Fig. 7A, I–III shows pattern forming
micro cluster, incomplete macro cluster and compact micro
clusters, respectively. Whereas Fig. 7A, IV and V describes
large compact self-assembly of the conjugated nanoforms with
speciﬁc patterns. This diversity of self-assembly can be attrib-
uted to the ﬁbrous nature of the protein conjugated with the
gold nanoparticle (we have observed that in case of diﬀerent
globular proteins, there is no such pattern formation upon
gold conjugation). The thrombin–Ag however does not yield
such a variety of microstructures. They show small micro clus-
ters with any patterned self-assembly (see Fig. 7B, I and II).
Now, when the mixture of ﬁbrinogen–Au and thrombin–Ag
has been observed, we have found various self-assembled
nanoclusters formed due to various interactions during throm-
bin ﬁbrinogen interaction. The population is however a net-
working assembly of the aggregated protein-conjugated
nanoparticles, as described in Fig. 7C, I –IV. They are repre-
sentative of the ﬁbrin formation.
3.7. Broadening of the size distribution upon interaction
From the DLS measurement (see Fig. 8), the hydrodynamic
size of the ﬁbrinogen–Au assembly was observed as 37.84 nmFig. 8. The alteration of the size distribution due to ﬁbrin formation has bee
describes the broadening of the size after interaction between ﬁbrinogen–Auand that of thrombin–Ag assembly was found as 58.77 nm.
When these solutions were mixed with 1:1 volume ratio, we
get a broad distribution of size with the maxima at 164.2 nm
(see Fig. 8). The broadening of this distribution is probably
due to the self-assembly of the protein-conjugated nanoparti-
cles upon interaction.
3.8. Change in electrokinetic properties
In the laser Doppler velocimetry technique, the conductance
of the solutions was measured. The individual nanoforms show
similar conductance values; i.e. 19.57 mS/cm for ﬁbrinogen–
Au and 22.4 mS/cm for thrombin–Ag. But, for the 1:1 mixture
of the two, we observed a sharp decrease of the value, which is
1.024 mS/cm. This decrease of conductance reﬂects the in-
creased bulk of the ﬁbrin network, formed during the interac-
tion between the two nanoforms.4. Discussion
The paper presents a ﬂow cytometric approach to study
interaction between two proteins, ﬁbrinogen and thrombin
subjected to conjugation with two respective nanomaterials,
gold and silver. The hemostatic role of ﬁbrin formation is im-
mense. The ﬁbrin formation process is sensitive to any defect in
either ﬁbrinogen or thrombin, and in clinical terms such de-
fects may lead to various hematological disorders, e.g. chance
of higher or lower thrombus formation. Since the defects in
such interaction are likely to be reﬂected in the analytical pro-
cedure described here, a clinical utility of the approach is evi-
dent.
A critical point to be addressed in this context is how the
analysis becomes helpful to explore some intricate feature of
this important interaction. Though the ﬁnal outcome of the
interaction (namely, formation of ﬁbrin) is not explicit, the vi-
sual emergence of a new population with altered cluster prop-
erty in response to an interacting component (thrombin–Ag)
provides an evidence of the change in protein oligomericity
as a result of such interaction. Apart from the methodological
novelty, the procedure thus provides a geometric insight of the
interaction. The progress of the interaction is mapped into a
plane spanned by two angles of scattering, one reﬂecting the
variation of cluster size and the other the granularity. Decrease
in FSC implies compaction of size while the increase in SSC
implies increase in granularity which may be possible onlyn shown by dynamic light scattering experiment. The size distribution
and thrombin–Ag.
5542 S. Roy, A.K. Dasgupta / FEBS Letters 581 (2007) 5533–5542for porous and extended clusters (e.g. the diﬀusion limited
clusters). Such information regarding protein–protein interac-
tion is hardly revealed in conventional proteomic approaches.
One distant comparison of this method may be one of our ear-
lier work on mapping the folding state using the Rg–f plot in
which the ﬁrst and second representation dimensions were
hydrodynamic radius and zeta potential [23]. That method
yielded the important information regarding the size variation
of proteins with progress of its folding state. In ﬂow cytometric
method however the folding information is blinded (data not
shown) due to the requirement of a high dilution.
In the present case it however follows that the possible appli-
cation of this procedure is not limited to exploration for the re-
ferred set of proteins but can be extended in studying other
protein–protein interaction of physiological importance.
Importantly, the technique can be used to study mutual inter-
action of proteins with higher versatility, if one of the interact-
ing partners is ﬂuorescent (say quantum dot or ﬂuorescent
antibodies). In such cases one can go beyond FSC–SSC planes,
and probe into energy state changes along with the changes in
protein oligomericity during such interactions.
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